野生动植物入药受限应及早应对

• 出 处: 河北中医
• 发表日期: 2000年12期
• 关键词: 中药企业 犀牛角 濒危物种 虎骨 原料药材 濒危野生动植物 代用品 国家保护 珍稀濒危植物 资源保护利用

野生动植物入药受限制已成为必然趋势 ,中药企业对此应有必理准备 ,及早寻求应对措施。我国是濒危野生动植物种国际贸易公约的缔约国之一 ,国家保护野生动植物 ,尤其是珍稀濒危野生动植物的力度在不断加大。 1987年国务院颁布了《野生药材资源保护管理条例》 ,1993年发出了《关

Restricted access to drugs for wildlife has become an inevitable trend, and Chinese medicine companies should be prepared for this and seek response measures as soon as possible. China is one of the signatories to the International Trade Convention on Endangered Species of Wild Fauna and Flora. The State’s efforts to protect wild animals and plants, especially rare and endangered wildlife, is increasing. In 1987, the State Council promulgated the Regulations on the Protection and Management of Wild Medicinal Materials, which was issued in 1993.